(a) Local and regional:

  1. Histopathology of hepatitis C infection. Central Blood Bank of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA, January 1992.
  2. Humoral and Cellular Immunity in Transplantation. Graduate Student Lecture Series, University of Pittsburgh, Pittsburgh, January 1994.
  3. The Renal Biopsy: Principles of Evaluation by Light, Immunofluorescence and Electron Microscopy. Continuing Education Conference for Pathologists' Assistants, Department of Pathology, University of Pittsburgh, April 1994.
  4. Correlation of hepatitis C virus reverse transcriptase polymerase chain reaction and transplant pathology. Molecular Diagnostics Infectious Disease Section Seminar, Department of Pathology, University of Pittsburgh, February 1995.
  5. Interpretation of liver biopsies obtained from liver transplant recipients with hepatitis C infection. University of Pittsburgh Medical Center Diagnostic Pathology Conference, June 1995.
  6. Evaluation of post-transplant renal allograft dysfunction by needle biopsy, using the Banff Schema. Reference Laboratory Alliance sponsored course titled "What's New in Laboratory Medicine". Sheraton Hotel, Pittsburgh, PA., November 1995.
  7. Hepatitis C infection. Pittsburgh Pathology Society Case Presentation, Pittsburgh,PA, February 1996.
  8. Pathologic changes after renal transplantation. Pittsburgh Transplantation Institute Conference, Holiday Inn, Pittsburgh, PA, April 1996.
  9. Viral infections in the renal allograft. University of Pittsburgh Medical Center Diagnostic Pathology Conference, June 1996.
  10. Pathologic changes after renal transplantation, Pittsburgh Transplantation Institute Conference, University of Pittsburgh Medical Center, Pittsburgh, PA, May 24, 1997.
  11. The Banff Schema for the classification of renal allograft pathology. University of Pittsburgh Medical Center Diagnostic Pathology Conference, June 1997.
  12. Polyoma virus infections after renal transplantation, Division of Transplantation Pathology Scientific Research Meeting Series, Pittsburgh, PA, October 1, 1998.
  13. Renal allograft pathology. Department of Medicine Seminar for Fellows in Nephrology, April 1998 and 1999.
  14. The Pathology of Drug Toxicity in the Allograft Pathology. University of Pittsburgh Medical Center Diagnostic Pathology Conference, March 2000.
  15. Kidney Transplant Pathology I and II. Didactic Lecture Series for Residents, Department of Pathology, University of Pittsburgh Medical Center, January 2001.
  16. Polyomavirus infections after kidney transplantation: the continuing saga. Division of Transplantation Pathology Scientific Research Meeting Series, Pittsburgh, PA, September 25, 2003.
  17. Gene expression in BKV infected WI-38 cells: an analysis by DNA microarray analysis. Division of Transplantation Pathology Scientific Research Meeting Series, Pittsburgh, PA, April 9, 2003.
  18. Polyomaviruses in organ transplant recipients: from latent infection to overt clinical disease. The Thomas E Starzl Institute Conference Series, Pittsburgh, PA, March 9, 2005
  19. An update on polyomavirus infection after kidney transplantation.. The Thomas E Starzl Institute Research Retreat, Pittsburgh, PA, September 25, 2005.
  20. Polyomavirus infections. UPMC-Palermo, August 2nd, 2005.
  21. The Anti-BKV drug discovery program. Division of Transplantation Pathology Scientific Research Meeting Series, Pittsburgh, PA, November 2nd, 2005.
  22. A primer on renal transplantation pathology. University of Pittsburgh Medical Center Diagnostic Pathology Conference, January 12, 2006.
  23. Renal allograft pathology. Department of Medicine Seminar for Fellows in Nephrology, 2004-2010.
  24. Research That Matters (an overview of research on BK virus to the general public). Thomas E Starzl Transplantation Institute, October 10, 2007.
  25. Expanded criteria donors: a pathologist's perspective. Center for Organ Recovery and Education, Pittsburgh, PA, May 11, 2008.
  26. Diagnosis of Acute Rejection in Kidney Transplant Recipients. Department of Surgery Transplant Lecture Series for Fellows in Transplantation Surgery, March 26, 2010.
  27. BK virus: diagnosis and management. Department of Medicine, Core Curriculum Lecture Series for Fellows in Infectious Disease, June 11, 2010.


(b) National:

  1. Lymphoproliferative disorders in heart-lung transplant recipients. United States and Canadian Academy of Pathology Meeting, San Francisco, March 1989.
  2. Epstein-Barr virus infection in immunosuppressed liver transplant recipients. United States and Canadian Academy of Pathology Meeting, Boston, March 1990.
  3. The pathology of post-transplant bronchiolitis obliterans. Department of Pathology, University of Kansas Medical Center, Kansas City, Kansas. November 1990.
  4. The systemic distribution of Epstein-Barr virus genomes in fatal post-transplant lymphoproliferative disorders, United States and Canadian Academy of Pathology Meeting, Chicago, IL, March, 1991.
  5. Expression of Epstein-Barr virus encoded small RNA's (EBER's)in liver biopsies precedes development of post-transplant lymphoproliferative disease. United States and Canadian Academy of Pathology Meeting, Atlanta Georgia, March 1992.
  6. FK506 microvascular toxicity in renal allografts. US & Canadian Academy of Pathology Meeting, Toronto, Canada, March 1995.
  7. Differentiation of renal Epstein-Barr virus (EBV) associated post-transplant lymphoproliferative disease (PTLD) from severe acute rejection (AR), using the Banff Schema. US & Canadian Academy of Pathology Meeting, Washington D.C., March 1996.
  8. BK virus infection after kidney transplantation, Renal Pathology Society Evening Specialty Conference, United States and Canadian Academy of Pathology Meeting, Washington, DC, March 27, 1996.
  9. Renal allograft infiltrates that mimic acute rejection, American Society of Nephrology Meeting, San Antonio, TX, November 3, 1997.
  10. Polyoma virus infection after renal transplantation (a computerized interactive response system based teaching exercise). Israel Penn Transplantation Fellows Symposium, Scottsdale, Arizona, October 27-30, 1999.
  11. Post-transplant lymphoproliferative disease in the allograft kidney. US & Canadian Academy of Pathology Meeting, Evening Renal Pathology Specialty Conference, Atlanta, GA, March 7, 2001.
  12. Epstein-Barr virus associated post-transplant lymphoproliferative disease presenting in the allograft common bile duct. US & Canadian Academy of Pathology Meeting, Evening Liver Pathology Specialty Conference, Atlanta, GA, March 4, 2001.
  13. Polyomavirus and its consequences. American Society of Transplantation Meeting, Clinical Science Symposium: "Infectious complications of transplantation: revisiting the old and understanding the new".Chicago, IL, May 15, 2001.
  14. A conceptual approach to transplantation pathology. 2002 Transplant Fellows Conference: Advances in Organ Transplantation, Dallas, Texas, March 16, 2002.
  15. Polyomavirus infection after renal transplantation, Laboratory of Pathology, National Cancer Institute, NIH, Bethesda, MD, May 16, 2002.
  16. Polyomavirus nephropathy after kidney transplantation: a pathologist's perspective. NIH workshop titled 'Polyomavirus nephropathy in immunosuppressed kidney and other solid organ transplant recipients'. Organized by Division of Allergy, Immunology, and Transplantation, National Institute of Allergy and Infectious Disease, and office of Rare Diseases, NIH, Bethesda, MD, August 13-14, 2002.
  17. The expanding spectrum of polyomavirus infections. Infectious Disease, Molecular Microbiology, & Immunology Joint Seminar, Department of Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, September 11, 2003.
  18. Polyomavirus associated diseases in the transplanted patient. Pre-Meeting Symposium on " Infection in transplantation: state of the art and future challenges". American Transplant Congress, Boston, May 15, 2004
  19. BK, JC, and SV40 infections in the allograft kidney. Medical School of Wisconsin, Milwaukee, WI, August 24, 2004.
  20. Post-transplant infectious disease, a pathologist's perspective. Fujisawa sponsored roundtable meeting titled "Individualizing Transplant Care for Chronic and Acute Diseases'. Chicago Hilton, Chicago, IL, August 27, 2004.
  21. Role of the Pathologist in the Management of Kidney Transplant Patients. Transplant Grand Rounds, The Rhode Island Hospital, Providence, Rhode Island, October 29, 2004
  22. BK polyomavirus: an emerging infection in kidney transplant patients. Plenary talk at Association of Molecular Pathologist's Meeting, The Century Plaza Hotel, Los Angeles, California, November 11, 2004.
  23. BK, JC, and SV40 infections in kidney transplant recipients. Satellite Health Care Research Symposium, Washington DC, May 9, 2005.
  24. The search for anti-BK virus drugs. International Polyomavirus Investigator Conference, Baltimore, Maryland, May 19, 2005.
  25. Comparative analysis of JC and BK polyomavirus load in solid organ transplant recipients and non-transplant controls. American Transplant Congress, Seattle, WA, May 22, 2005,
  26. Pathobiology of polyomavirus infection in man. American Transplant Congress, In Depth Clinical Reviews, Seattle, WA, May 23, 2005.
  27. In-vitro testing program for BK virus. Department of Microbiology and Infectious Disease, NIAID, NIH, Bethesda, Maryland, June 3, 2005.
  28. Potential therapeutic targets for anti-BK virus drugs. International Conference on Polyomaviruses and Human Diseases. Brown University, Providence, Rhode Island, September 13, 2005.
  29. Annual update on the in-vitro testing program for BK virus. Department of Microbiology and Infectious Disease, NIAID, NIH, Bethesda, Maryland, April 26, 2006.
  30. Interpretation of kidney allograft biopsies and update on BK virus nephropathy. Department of Surgery, Downstate Medical Center, Brooklyn, New York, September 5, 2006.
  31. Pathology of chronic allograft nephropathy. American Society of Nephrology Renal Week, San Diego, November 15, 2006.
  32. Viral infections in the renal allograft. Lecture as a part of a course titled Renal Biopsy Interpretation: controversies and challenges. Washington University at St Louis, MO, March 16, 2007.
  33. Annual update on the in-vitro testing program for BK virus. Department of Microbiology and Infectious Disease, NIAID, NIH, Bethesda, Maryland, May 23, 2007.
  34. Screening for Potential Anti-BK Polyomavirus Compounds Using Cell Culture and a Real Time PCR Based Assay. American Transplant Congress, San Francisco, May 6, 2007.
  35. Polyomavirus BK Non-Coding Control Region Rearrangements in Health and Disease. American Transplant Congress, San Francisco, May 8, 2007.
  36. Disruption of the Life Cycle of Polyomavirus by Drugs Interfering with Viral Uptake and Intracellular Transport. American Transplant Congress, San Francisco, May 8, 2007.
  37. Pathology of chronic allograft nephropathy. American Society of Nephrology Renal Week, San Francisco, November 01, 2007.
  38. Polyomavirus BK: a bad kidney virus. St John's Hospital, Detroit, Michigan, December 14, 2007.
  39. Annual update on the in-vitro testing program for BK virus. Department of Microbiology and Infectious Disease, NIAID, NIH, Bethesda, Maryland, May 15, 2008.
  40. Pathology of chronic allograft nephropathy. American Society of Nephrology Renal Week, Philadelphia, November 2008.
  41. Basic principles of renal transplantation pathology. Via Christi Medical Center, Wichita, Kansas, March 24, 2009.
  42. Polyomavirus BK: a Polyomavirus infection: a potential nightmare for the renal transplant team. Via Christi Medical Center, Wichita, Kansas, March 24, 2009.
  43. Annual update on the in-vitro testing program for BK virus. Department of Microbiology and Infectious Disease, NIAID, NIH, Bethesda, Maryland, March 31, 2009.
  44. Rational Design of Anti-BK Virus (BKV) Drugs Targeting Functional Domains on BKV Large T-Antigen (LTA). ATC Meeting, American Society of Transplantation, John B. Hynes Convention Center, Boston Massachusetts, May 30-June 3, 2009.
  45. The Significance of Renal C4D Deposits In Patients With BK Viruria, Viremia, and Nephropathy. ATC Meeting, American Society of Transplantation, John B. Hynes Convention Center, Boston Massachusetts, May 30-June 3, 2009.
  46. American Society of Transplantation Infectious Disease Guidelines on Monitoring BKV infection after kidney transplantation. Interactive Symposium on AST/IDSA Guidelines: Managing Viral Infections. Infectious Disease Society of America Meeting, Philadelphia, PA, October 30, 2009.
  47. Update on Renal Transplant Pathology. Society of Pediatric Pathology, Annual Meeting. Washington DC, March 21, 2010.
  48. Annual update on the in-vitro testing program for BK virus. Department of Microbiology and Infectious Disease, NIAID, NIH, Bethesda, Maryland, March 31, 2010.
  49. Role of a Renal Allograft Biopsy in the Management of Kidney Transplantation Patients. Surgical Pathology of Solid Organ Transplantation, May 7, University of Pittsburgh, Pittsburgh, May 7, 2010.
  50. Infectious Disease in Transplantation Pathology. Surgical Pathology of Solid Organ Transplantation, May 8, University of Pittsburgh, Pittsburgh, May 7, 2010.


(c) International:

  1. The hormonal regulation of antioxidant enzymes in the rat lung", Department of Pathology, All India Institute of Medical Sciences, New Delhi, India, December, 1986.
  2. The pathogenesis and pathology of acute cardiac allograft rejection. National Symposium on Heart Transplantation. Beijing Heart Lung and Blood Vessel Medical Center. Beijing, China, October 1992.
  3. The spectrum of histopathologic lesions observed in recipients of heart transplantation. National Symposium on Heart Transplantation. Beijing, China, October 1992.
  4. The pathology of lung transplantation. Department of Pathology, Anzhen Hospital, Beijing, China, October 1992.
  5. The pathology of liver transplantation. Department of Pathology, Anzhen Hospital, Beijing, China, October 1992.
  6. Epstein-Barr virus infections after solid organ transplantation. Department of Pathology, Anzhen Hospital, Beijing, China. October 1992.
  7. The pathology of liver transplantation. Department of Pathology, Anzhen Hospital, Beijing, China, October 1992.
  8. Role of the pathologist in diagnosing infections in liver transplant recipients. Second Congress of the International Liver Transplantation Society, Toronto, October 1993.
  9. The histopathology of liver allografts. Seventh International Workshop on Transplant Cytology, Immunology & Histology, Buenos Aires, Argentina, November 1993.
  10. Cell migration & chimerism after liver transplantation. Fourth Argentine Congress of Transplantation, Buenos Aires, Argentina, November 1993.
  11. Current overview of xenotransplantation. Fourth Argentine Congress of Transplantation, Buenos Aires, Argentina, November 1993.
  12. The Influence of Donor and Recipient Hepatitis C status on the outcome of Liver Transplantation. International Symposium on Hepatitis C Viral Infection and Liver Transplantation, Universite Catholique de Louvain, Brussels, Belgium, October 1994.
  13. Clinical and pathological aspects of hepatitis C infection after liver transplantation. Department of Pathology, All India Institute of Medical Sciences, New Delhi, India, July 1995.
  14. Antibody mediated rejection in the allograft liver. The Transplantation Society, XVII Congress, Montreal, Quebec, Canada, July 13-17, 1998.
  15. The Pathology of Liver Allograft Rejection. 11th World Congress of Gastroenterology, Vienna, Austria, September 9, 1998
  16. BK, CMV, and Epstein-Barr virus infections in the allograft kidney. Banff Conference on Allograft Pathology, Banff, Alberta, Canada, June 7-12, 1999.
  17. The pathology of allograft rejection after solid organ transplantation. American Society of Transplantation Meeting: Transplantation 1999-Comprehensive Update & Review, Toronto, Canada, July 31- August 1, 1999.
  18. Post-transplant lymphoproliferative disease in the allograft kidney. European Society of Pathology Meeting, Barcelona, Spain, September 18-23, 1999.
  19. Diagnosis of Viral Infections after Transplantation. International Academy of Pathology Meeting, Nagoya, Japan, October 17, 2000.
  20. Pathologic assessment of donor kidney biopsies. Sixth Banff Conference on Allograft Pathology, Banff, Alberta, Canada, April 24, 2001.
  21. A proposal for grading changes in donor biopsies. Sixth Banff Conference on Allograft Pathology, Banff, Alberta, Canada, April 24, 2001.
  22. Viral infections in allografts: diagnosis & pathogenic factors with special references to polyomavirus infection. Sixth Banff Conference on Allograft Pathology, Banff, Alberta, Canada, April 25, 2001.
  23. JC virus infection in the kidney. Sixth Banff Conference on Allograft Pathology, Banff, Alberta, Canada, April 24, 2001.
  24. Summary report on plenary session 'Morphologic criteria for donor selection in kidney transplantation'. Sixth Banff Conference on Allograft Pathology, Banff, Alberta, Canada, April 27, 2001.
  25. Summary report on plenary session 'Viral infections in allografts'. Sixth Banff Conference on Allograft Pathology, Banff, Alberta, Canada, April 27, 2001.
  26. Histopathology of BKV nephropathy. International Polyomavirus Consensus Conference, Basel, Switzerland, October 17, 2003.
  27. Cidofovir therapy for BKV infection in kidney transplant patients. International Polyomavirus Consensus Conference, Basel, Switzerland, October 17, 2003.
  28. The Pathology of Acute Renal Allograft Dysfunction. Update in Kidney Transplantation, Kuwait City, Kuwait, January 12, 2004. Conference organized by The Kuwait Transplant Society and The Hamad Al-Essa Organ Transplant Center to commemorate 25 years of kidney transplantation in the State of Kuwait.
  29. The Pathology of Chronic Renal Allograft Dysfunction. Update in Kidney Transplantation, Kuwait City, Kuwait, January 12, 2004. Conference organized by The Kuwait Transplant Society and The Hamad Al-Essa Organ Transplant Center to commemorate 25 years of kidney transplantation in the State of Kuwait.
  30. Polyomavirus infections at the University of Pittsburgh. Research Seminar Series, Mediterranean Institute of Transplantation and Specialized Therapies, Palermo, Italy, August 2nd, 2005.
  31. Strategies to screen for polyomavirus infection in renal transplant patients. Belgian Society of Clinical Cytology Meeting, Liege, Belgium. October 21, 2006.
  32. Case studies of polyomavirus infection after kidney transplantation. Belgian Society of Clinical Cytology Meeting, Liege, Belgium. October 21, 2006.
  33. Pathology of acute allograft dysfunction. 10th Congress of the Middle East Society of Organ Transplantation, Kuwait City, Kuwait, November 29, 2006.
  34. Pathology of chronic allograft nephropathy. 10th Congress of the Middle East Society of Organ Transplantation, Kuwait City, Kuwait, November 29, 2006.
  35. BK virus screening: why, when and how?. 3rd International Transplant Infectious Disease Conference. Prague, Czech Republic, September 30, 2007.
  36. Progress in the discovery of anti-BK virus drugs. International Conference on polyomaviruses and human disease. Barcelona, Spain, October 2, 2007.
  37. BK virus: current screening and monitoring recommendations. American Transplant Congress, Toronto, June 4, 2008.
  38. BK Virus Nephropathy: Why do we need a pathologist for clinical management. XXII International meeting of the Transplantation Society Meeting. Sydney, Australia, August 10-14, World Transplant Congress, 2008.
  39. New Diagnostic and Therapeutic Tools for BKV infection. World Society of Nephrology, Milan, Italy, May 25, 2009.
  40. Virus Induced Pathology in Renal Allografts. Wyeth Inc. 2nd Workshop of Clinical-Pathologic Correlation in Kidney Transplantation, Bogota, Colombia, June 12-13, 2009.
  41. Unusual Causes of C4d Deposition in Renal Allografts. Wyeth Inc. 2nd Workshop of Clinical-Pathologic Correlation in Kidney Transplantation, Bogota, Colombia, June 12-13, 2009.
  42. Urine Cytology Findings in Polyomavirus Infection. Wyeth Inc. 2nd Workshop of Clinical-Pathologic Correlation in Kidney Transplantation, Bogota, Colombia, June 12-13, 2009.
  43. Footprints of Drug Toxicity in the Transplanted Kidney. Wyeth Inc. 2nd Workshop of Clinical-Pathologic Correlation in Kidney Transplantation, Bogota, Colombia, June 12-13, 2009.
  44. Focal Deposits of Complement Degradation Product C4d in Renal Allografts. 10th Banff Conference on Allograft Pathology, Banff, Canada, August, 10, 2009